Prosecution Insights
Last updated: May 29, 2026
Application No. 17/921,997

METHOD FOR BREAKING DOWN MICHAEL ADDUCTS CONTAINED IN A FLUID F AND FORMED DURING THE PREPARATION OF ACRYLIC ACID

Non-Final OA §103§112
Filed
Oct 28, 2022
Priority
May 04, 2020 — EU 20172654.4 +1 more
Examiner
DOLETSKI, BLAINE G
Art Unit
1692
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
BASF Corporation
OA Round
2 (Non-Final)
75%
Grant Probability
Favorable
2-3
OA Rounds
0m
Est. Remaining
83%
With Interview

Examiner Intelligence

Grants 75% — above average
75%
Career Allowance Rate
416 granted / 552 resolved
+15.4% vs TC avg
Moderate +8% lift
Without
With
+7.7%
Interview Lift
resolved cases with interview
Fast prosecutor
2y 0m
Avg Prosecution
17 currently pending
Career history
578
Total Applications
across all art units

Statute-Specific Performance

§101
0.5%
-39.5% vs TC avg
§103
61.3%
+21.3% vs TC avg
§102
10.3%
-29.7% vs TC avg
§112
3.6%
-36.4% vs TC avg
Black line = Tech Center average estimate • Based on career data from 552 resolved cases

Office Action

§103 §112
Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . DETAILED ACTION Claim Status Claims 16-30 are pending. Claims 16-29 are under examination. Claims 16-29 are rejected. No claims allowed. Filing Receipt PNG media_image1.png 144 982 media_image1.png Greyscale PNG media_image2.png 46 974 media_image2.png Greyscale PNG media_image3.png 82 974 media_image3.png Greyscale PNG media_image4.png 46 972 media_image4.png Greyscale PNG media_image5.png 70 972 media_image5.png Greyscale Response to Amendments/Arguments Applicant's amendments and arguments filed 12/17/2025 are acknowledged and have been fully considered. The Examiner has re-weighed all the evidence of record. Any rejection and/or objection not specifically addressed below in original or modified form is herein withdrawn. Withdrawn Rejections The 102 rejection of claims 16 and 26 as anticipated by Schliephake et al. (USPGPub 2012/0258019, Published 10-2012) as evidence by Schliephake et al. in the non-final mailed 09/17/2026 has been withdrawn. The claim amendments have overcome the rejection. The following modified 112(b), and 103 rejections constitute the complete set of rejections and/or objections presently being applied to the instant application. Response to Arguments Applicant's arguments filed 12/17/2025 have been fully considered but they are not persuasive. 112(b) rejection Concerning the 112(b) rejections, applicant argues the amendments to the claims are believed to be sufficient to obviate the stated grounds for rejection. The examiner does not agree. Concerning the newly added limitation of “observing” an unwanted rise in the viscosity, this is addressed in the modified 112(b) rejection below. Concerning the 112(b) rejection of independent claim 16 and wherein the splitting in the redissociation apparatus occurs, no amendments were presented to obviate the indefiniteness rejection. Concerning the newly added limitation “a splitting apparatus” in claim 26. This limitation does not have support in the independent claim 16 from where claim 26 depends. The only apparatus in claim 16 is the redissociation apparatus. 102 Rejection The 102 rejection has been withdrawn. 103 Rejection Applicant argues the newly added limitation of “observing” an unwanted rise in viscosity is not taught by the prior art. The below 103 rejection was modified to address this limitation. Applicant additionally argues the prior art Schliephake does not disclose or suggest diluting and cooling the residue with at least 10%/V of solvent 1. The Schliephake reference was not utilized to teach the diluting and cooling. See the original non-final rejection mailed 09/17/2025 pages 10-11 wherein Yada et al. was supplied to show cooling occurs when adding solvents and Sakamoto et al. taught the claimed dilution. For the reasons stated above the obviousness rejection is maintained/modified as set forth below. Claim Interpretation This claim interpretation was necessitated by amendment. The phrase “observing an unwanted rise in viscosity” in textual line 11 of claim 16, requires an observed unwanted rise in viscosity. The observed unwanted rise in viscosity is not defined in the specification. Therefore, the observed unwanted rise in viscosity can mean any amount of viscosity. The “split” limitation in claim 16 is interpreted to be the “splitting” of the Michael adducts to prepare the redissociation products. See page 3 of the current specification. Claim Rejections - 35 USC § 112 The following is a quotation of 35 U.S.C. 112(b): (b) CONCLUSION.—The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the inventor or a joint inventor regards as the invention. The following is a quotation of 35 U.S.C. 112 (pre-AIA ), second paragraph: The specification shall conclude with one or more claims particularly pointing out and distinctly claiming the subject matter which the applicant regards as his invention. Claims 16-29 are rejected under 35 U.S.C. 112(b) or 35 U.S.C. 112 (pre-AIA ), second paragraph, as being indefinite for failing to particularly point out and distinctly claim the subject matter which the inventor or a joint inventor (or for applications subject to pre-AIA 35 U.S.C. 112, the applicant), regards as the invention. The modifications to this rejection were necessitated by amendment. Claim 16 does not define where the redissociation (split) products are prepared in the redissociation apparatus. This location may be the pump or the evaporator V or the top/bottom spaces or within the separating internals. The phrase “observing an unwanted rise in viscosity” in textual line 11 of claim 16, requires an observed unwanted rise in viscosity. The observed unwanted rise in viscosity is not defined in the specification. The observed unwanted rise in viscosity may be the “very viscous” residue in example 3 page 15 of the specification. However, without clarity an amount of an observed unwanted rise in viscosity is unclear. Claims 26-27 recite the limitation "a splitting apparatus". There is insufficient antecedent basis for this limitation in the claim. Claim 16 from where claims 26-27 depend describes the redissociation apparatus comprising a column K. Claims 26-27 read as if the splitting apparatus is above the bottoms liquid and below the lower most separating internals of the separating column K. Claim Rejections - 35 USC § 103 The following is a quotation of 35 U.S.C. 103 which forms the basis for all obviousness rejections set forth in this Office action: A patent for a claimed invention may not be obtained, notwithstanding that the claimed invention is not identically disclosed as set forth in section 102, if the differences between the claimed invention and the prior art are such that the claimed invention as a whole would have been obvious before the effective filing date of the claimed invention to a person having ordinary skill in the art to which the claimed invention pertains. Patentability shall not be negated by the manner in which the invention was made. The factual inquiries for establishing a background for determining obviousness under 35 U.S.C. 103 are summarized as follows: 1. Determining the scope and contents of the prior art. 2. Ascertaining the differences between the prior art and the claims at issue. 3. Resolving the level of ordinary skill in the pertinent art. 4. Considering objective evidence present in the application indicating obviousness or nonobviousness. This application currently names joint inventors. In considering patentability of the claims the examiner presumes that the subject matter of the various claims was commonly owned as of the effective filing date of the claimed invention(s) absent any evidence to the contrary. Applicant is advised of the obligation under 37 CFR 1.56 to point out the inventor and effective filing dates of each claim that was not commonly owned as of the effective filing date of the later invention in order for the examiner to consider the applicability of 35 U.S.C. 102(b)(2)(C) for any potential 35 U.S.C. 102(a)(2) prior art against the later invention. Claim(s) 16-29 is/are rejected under 35 U.S.C. 103 as being unpatentable over Schliephake et al. (USPGPub 2012/0258019, Published 10-2012), Sakamoto et al. (US Patent 6,414,183, Patent date 07-2002) and as evidence by Yada et al. (USPGPub2005/0192462, Published 09-2005). The modifications to this rejection were necessitated by amendment. Scope of the Prior Art Schliephake et al. teach the following. PNG media_image6.png 234 620 media_image6.png Greyscale PNG media_image7.png 84 622 media_image7.png Greyscale Concerning the claimed evaporator V, this is the “indirect circulation heat exchanger” taught by Schliephake et al. in the above paragraph 174. The reason being the stream exiting the “indirect circulation heat exchanger” in paragraph 174 boils. PNG media_image8.png 140 620 media_image8.png Greyscale PNG media_image9.png 136 620 media_image9.png Greyscale PNG media_image10.png 140 620 media_image10.png Greyscale Above, the substream I flows into the one secondary space of the circulation heat exchanger UW while the substream II leaving the one secondary space of the circulation heat exchanger UW boils. The secondary space of the circulation heat exchanger UW is the claimed evaporator V. The boiling is the claimed gas phase. The above process of redissociation in paragraph 174 of Schliephake et al. is the claimed splitting of the Michael adducts in current claim 16. The below TRS is the claimed splitting temperature. See below paragraph 174 of Schliephake et al. PNG media_image11.png 146 624 media_image11.png Greyscale PNG media_image12.png 132 616 media_image12.png Greyscale PNG media_image13.png 134 626 media_image13.png Greyscale The TRS overlapds the claimed 130 to 240C. See Schliephake et al. paragraph 137-138. PNG media_image14.png 110 618 media_image14.png Greyscale PNG media_image15.png 142 626 media_image15.png Greyscale Concerning claim 26, Schliephake et al. teach the following. PNG media_image16.png 136 620 media_image16.png Greyscale Concerning the solvent 1, diluting and emptying the bottom space of the separating column K, the closest teaching by Schliephake et al. is in paragraph 166. PNG media_image17.png 190 624 media_image17.png Greyscale Concerning the cooling during the dilution, this is known to occur when adding solvents as evidence by Yada et al. paragraph 5. Concerning claim 17, Schliephake et al. teach at least 40% (par. 67). This overlaps with the current range. Concerning the splitting temperatures of claims 16 and 18, Schliephake et al. teach overlapping temperatures (par.137-138). Concerning claim 22, Schliephake et al. teach ethylene glycol (par. 56). Ascertain the Differences Schliephake et al. does not teach observing an unwanted rise in viscosity, diluting the residue R in the bottom space of the separating column K to 10% by volume of the solvent and emptying the bottom space of the separating column K. Secondary References Concerning the observing of an unwanted rise in viscosity of the residue R, Sakamoto et al. teach “There is no limitation on the viscosity of the waste oil which is to be treated by the present inventive method” (column 7 lines 3-15). Sakamoto et al. goes on to teach (column 7, lines 3-15). PNG media_image18.png 156 481 media_image18.png Greyscale Due to the specification not defining the observed rise in unwanted viscosity, the viscosity teachings of Sakamoto et al. overlap the currently claimed unwanted rise in viscosity. Concerning discharging of the residue R, Sakamoto et al. teach removing waste oil from a distillation bottoms to a storage tank (Figure 3 and Column 2 and column 7). The removal is the claimed emptying due to the only contents of the below column being the waste oil. See Example 1 of Sakamoto et al. PNG media_image19.png 154 496 media_image19.png Greyscale PNG media_image20.png 108 498 media_image20.png Greyscale PNG media_image21.png 514 872 media_image21.png Greyscale The above solvent being placed into the storage tank is the currently claimed solvent 2. Moreover, Sakamoto et al. teach use of solvents in combination (column 5, lines 50-60). Concerning the claimed at least 10%, Sakamoto et al. teach 20 mass percent (Example 1). This range overlaps with the current range. Sakamoto et al. teach overlapping solvents as taught by Schliephake et al. See Sakamoto et al. column 5 lines 1-14. PNG media_image22.png 156 480 media_image22.png Greyscale PNG media_image23.png 72 476 media_image23.png Greyscale Sakamoto et al. goes on to teach the solvent may be added directly to the waste oil in the distillation (bridging columns 5-6). PNG media_image24.png 136 490 media_image24.png Greyscale PNG media_image25.png 160 474 media_image25.png Greyscale The above draining is the claimed emptying. Sakamoto et al. teach ranges of temperatures of the waste oil, establishing temperature as a result effective variable (bridging columns 6 and 7). Temperature is also a result effective variable with respect to the retention and/or clogging of pipes by the viscous material at the bottoms of a distillation column for distilling acrylic acid as evidence by Yada et al. paragraph 5. Sakamoto et al. teach the amount of solvent may be properly determined in consideration of the viscosity of the waste oil (column 6, lines 40-60). Concerning claim 19, Sakamoto et al. teach the solvent can have a boiling point over 170C. This range overlaps the current range of at least 210C. Concerning claim 25, Sakamoto et al. teach 50 cP or lower at 100C (top of column 7). This range overlaps the current range. The above teachings overlap with the teachings of Schliephake et al. and render Sakamoto et al. analogous art to the invention. The overlapping with respect to distilling acrylic acid and generating bottoms that are removed. Obviousness It would have been prima facie obvious for an ordinary artisan before the effective filing date of the claimed invention to have emptied the separation column K after observing an unwanted rise in viscosity of the residue R. The ordinary artisan would have done so to store the residue R and to prevent clogging and or precipitation of solids in the column/pumps as instructed by Sakamoto et al. Moreover, Schliephake et al. teach preferably removing a substream from the column K for disposal. The teaching of the preferred amount is not a teaching away from all of the bottoms from column K being removed. Therefore, removal of all the residue in the column K is obvious. See MPEP 2123 II. “Disclosed examples and preferred embodiments do not constitute a teaching away from a broader disclosure or nonpreferred embodiments.” When emptying the column K, it would have been obvious to stop the feed. This would have been done to ensure the emptying is accomplished. As for the unexpected rise in viscosity, temperature is known to effect the viscosity as evidence by Yada et al. Concerning the dilution of the residue with at least 10% of a solvent, MPEP 2144.05 I.: “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976).” The solvent being methanol as taught by Schliephake et al. Concerning the solvent and claims 16, 20 and 22, and 28-29 the ethylene glycol taught by Schliephake et al. is an alcohol. Ethylene glycol has 2 carbons and thus falls within the alcohol solvents taught by Sakamoto et al. Thus, ethylene glycol is an obvious choice. "Products of identical chemical composition cannot have mutually exclusive properties." In re Spada, 911 F.2d 705, 709, 15 USPQ2d 1655, 1658 (Fed. Cir. 1990). A chemical composition and its properties are inseparable. Moreover, ethanol is taught by the prior art and solvent 2 has no required properties. Concerning solvent 2 being the same or different than solvent 1, Sakamoto et al. teach use of solvents singularly or in combination (column 5, lines 50-60). Thus using a second solvent is obvious. Concerning claim 17 and the at least 40% Michael adducts, MPEP 2144.05 I.: “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976).” Concerning the splitting temperatures of claims 16 and 18, MPEP 2144.05 I.: “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976).” Concerning claim 19, MPEP 2144.05 I.: “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976).” Concerning claim 23 and 28-29, the origin of the solvent is a product-by-process limitation. This limitation is not given patentable weight because the MPEP 2113 recites ““[E]ven though product-by-process claims are limited by and defined by the process, determination of patentability is based on the product itself. The patentability of a product does not depend on its method of production. If the product in the product-by-process claim is the same as or obvious from a product of the prior art, the claim is unpatentable even though the prior product was made by a different process.” In re Thorpe, 777 F.2d 695, 698, 227 USPQ 964, 966 (Fed. Cir. 1985). Additionally, Sakamoto et al. teach the solvents may be from other sources and may contain impurities (column 5 lines 1-14). This teaching renders the claimed processes to obtain the claimed solvents in pure and impure states to be obvious. Concerning claim 24, Sakamoto et al. teach the amount of solvent may be properly determined in consideration of the viscosity of the waste oil. The claimed amounts would have been determined via the viscosity of the drained residue through routine experimentation. MPEP 2144.05 II. A. and B. “[W]here the general conditions of a claim are disclosed in the prior art, it is not inventive to discover the optimum or workable ranges by routine experimentation.” In re Aller, 220 F.2d 454, 456, 105 USPQ 233, 235 (CCPA 1955). Concerning claim 25, MPEP 2144.05 I.: “In the case where the claimed ranges “overlap or lie inside ranges disclosed by the prior art” a prima facie case of obviousness exists. In re Wertheim, 541 F.2d 257, 191 USPQ 90 (CCPA 1976).” Concerning claim 27, there would be no need for the gas to be continually added upon draining of the column K. Due to the distillation and/or splitting being ended. Conclusion Applicant's amendment necessitated the new ground(s) of rejection presented in this Office action. Accordingly, THIS ACTION IS MADE FINAL. See MPEP § 706.07(a). Applicant is reminded of the extension of time policy as set forth in 37 CFR 1.136(a). A shortened statutory period for reply to this final action is set to expire THREE MONTHS from the mailing date of this action. In the event a first reply is filed within TWO MONTHS of the mailing date of this final action and the advisory action is not mailed until after the end of the THREE-MONTH shortened statutory period, then the shortened statutory period will expire on the date the advisory action is mailed, and any nonprovisional extension fee (37 CFR 1.17(a)) pursuant to 37 CFR 1.136(a) will be calculated from the mailing date of the advisory action. In no event, however, will the statutory period for reply expire later than SIX MONTHS from the mailing date of this final action. Any inquiry concerning this communication or earlier communications from the examiner should be directed to BLAINE G DOLETSKI whose telephone number is (571)272-2766. The examiner can normally be reached M-F 7-4 EST. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Scarlett Goon can be reached at (571)270-5241. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /B.G.D/ Examiner, Art Unit 1692 /Andrew D Kosar/Supervisory Patent Examiner, Art Unit 1625
Read full office action

Prosecution Timeline

Oct 28, 2022
Application Filed
Sep 17, 2025
Non-Final Rejection mailed — §103, §112
Dec 17, 2025
Response Filed
Feb 10, 2026
Final Rejection mailed — §103, §112
Apr 07, 2026
Response after Non-Final Action
May 11, 2026
Request for Continued Examination
May 12, 2026
Response after Non-Final Action

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12637420
METHOD FOR SEPARATION OF METHIONINE SULFOXIDE DIASTEREOMERS
5y 4m to grant Granted May 26, 2026
Patent 12630662
DISTILLATION OF POLYISOCYANATES
4y 4m to grant Granted May 19, 2026
Patent 12624188
METHOD FOR PRODUCING BIS-2-HYDROXYETHYL TEREPHTHALATE THROUGH CONTINUOUS DEPOLYMERIZATION
2y 2m to grant Granted May 12, 2026
Patent 12624189
PROCESS FOR RECYCLING POLYETHYLENE TEREPHTHALATE USING A SEPARATED FEEDSTOCK
1y 6m to grant Granted May 12, 2026
Patent 12617752
RAPIDLY METABOLIZED LIPID COMPOUND
1y 11m to grant Granted May 05, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

2-3
Expected OA Rounds
75%
Grant Probability
83%
With Interview (+7.7%)
2y 0m (~0m remaining)
Median Time to Grant
Moderate
PTA Risk
Based on 552 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month